Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1993
Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemicC L Kuiken, G Zwart, E Baan, et al.
AIDS (London, England)|April 1, 1993
Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: serological and genetic analysisG Zwart, T F Wolfs, R Bookelman, et al.
Applied and Environmental Microbiology|January 30, 1999
Changes in bacterial and eukaryotic community structure after mass lysis of filamentous cyanobacteria associated with virusesE J van Hannen, G Zwart, M P van Agterveld, et al.
Research in Virology|September 1, 1989
Antibody recognition of amino acid divergence within an HIV-1 neutralization epitopeJ Goudsmit, G Zwart, M Bakker, et al.
Virology|June 1, 1994
Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progressionG Zwart, L van der Hoek, M Valk, et al.
Systematic and Applied Microbiology|January 30, 1999
Nearly identical 16S rRNA sequences recovered from lakes in North America and Europe indicate the existence of clades of globally distributed freshwater bacteriaG Zwart, W D Hiorns, B A Methé, et al.
Applied and Environmental Microbiology|August 6, 2004
Analysis of structural and physiological profiles to assess the effects of Cu on biofilm microbial communitiesB Massieux, M E Y Boivin, F P Van Den Ende, et al.
Virology|April 1, 1991
Immunodominance and antigenic variation of the principal neutralization domain of HIV-1G Zwart, H Langedijk, L van der Hoek, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 5, 2017
Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registryR Pisters, S P G van Vugt, M A Brouwer, et al.
Pageof 2